These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7910824)

  • 21. Transglutaminase catalyses the modification of glutamine side chains in the C-terminal region of bovine beta-lactoglobulin.
    Coussons PJ; Price NC; Kelly SM; Smith B; Sawyer L
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):803-6. PubMed ID: 1350436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Component PP3 from bovine milk is a substrate for transglutaminase. Sequence location of putative crosslinking sites.
    Sørensen ES; Rasmussen LK; Petersen TE
    J Dairy Res; 1999 Feb; 66(1):145-50. PubMed ID: 10191480
    [No Abstract]   [Full Text] [Related]  

  • 23. Site-directed mutation in conserved anionic regions of guinea pig liver transglutaminase.
    Ikura K; Yu C; Nagao M; Sasaki R; Furuyoshi S; Kawabata N
    Arch Biochem Biophys; 1995 Apr; 318(2):307-13. PubMed ID: 7733658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transglutaminase cross-linking of the tau protein.
    Miller ML; Johnson GV
    J Neurochem; 1995 Oct; 65(4):1760-70. PubMed ID: 7561874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase reactivity of human involucrin.
    Lambert A; Ekambaram M; Robinson N; Eckert RL
    Skin Pharmacol Appl Skin Physiol; 2000; 13(1):17-30. PubMed ID: 10657763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif.
    Darnell GA; Antalis TM; Johnstone RW; Stringer BW; Ogbourne SM; Harrich D; Suhrbier A
    Mol Cell Biol; 2003 Sep; 23(18):6520-32. PubMed ID: 12944478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.
    Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS
    J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal peptide of the transglutaminase-activating metalloprotease inhibitor from Streptomyces mobaraensis accommodates both inhibition and glutamine cross-linking sites.
    Juettner NE; Schmelz S; Anderl A; Colin F; Classen M; Pfeifer F; Scrima A; Fuchsbauer HL
    FEBS J; 2020 Feb; 287(4):708-720. PubMed ID: 31420998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of guinea-pig liver transglutaminase cDNA in Escherichia coli. Amino-terminal N alpha-acetyl group is not essential for catalytic function of transglutaminase.
    Ikura K; Tsuchiya Y; Sasaki R; Chiba H
    Eur J Biochem; 1990 Feb; 187(3):705-11. PubMed ID: 1968007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization.
    Wilczynska M; Lobov S; Ohlsson PI; Ny T
    EMBO J; 2003 Apr; 22(8):1753-61. PubMed ID: 12682008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of a vitronectin binding region of plasminogen activator inhibitor-1.
    Padmanabhan J; Sane DC
    Thromb Haemost; 1995 May; 73(5):829-34. PubMed ID: 7482411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2.
    Mikus P; Ny T
    J Biol Chem; 1996 Apr; 271(17):10048-53. PubMed ID: 8626560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin.
    Valnickova Z; Enghild JJ
    J Biol Chem; 1998 Oct; 273(42):27220-4. PubMed ID: 9765243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
    Borth W; Chang V; Bishop P; Harpel PC
    J Biol Chem; 1991 Sep; 266(27):18149-53. PubMed ID: 1680857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the epsilon-(gamma-glutamyl)lysine cross-linking sites in alpha-lactalbumin polymerized by mammalian and microbial transglutaminases.
    Lee DS; Matsumoto S; Matsumura Y; Mori T
    J Agric Food Chem; 2002 Dec; 50(25):7412-9. PubMed ID: 12452668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
    Sipley JD; Alexander DS; Testa JE; Quigley JP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2933-8. PubMed ID: 9096324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
    Kahlem P; Terré C; Green H; Djian P
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14580-5. PubMed ID: 8962095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of amino- and carboxyl-terminal sequences of guinea pig liver transglutaminase: evidence for amino-terminal processing.
    Ikura K; Yokota H; Sasaki R; Chiba H
    Biochemistry; 1989 Mar; 28(5):2344-8. PubMed ID: 2566328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latency and substrate binding globally reduce solvent accessibility of plasminogen activator inhibitor type 1 (PAI-1). An adaptation of PAI-1 conformer crystal structures by hydrogen-deuterium exchange.
    Nukuna BN; Penn MS; Anderson VE; Hazen SL
    J Biol Chem; 2004 Nov; 279(48):50132-41. PubMed ID: 15337743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.